CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Net Loss	$ (518,128)	$ (250,322)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	44,830	54,923
Non-cash compensation	0	2,680
Bad debt (recovery)	0	(9,101)
Investment income	0	(2,750)
Bad debt	368	0
Gain on extinguishment		(228,261)
(Increase) decrease in:
Other receivables	8,991	26,148
Prepaid expenses	34,278	(8,668)
Mortgage escrow	21,615	0
Other assets	(30)	(218,051)
Increase (decrease) in:
Accounts payable and accrued liabilities	245,879	119,394
Other liabilities	9,203	(143,137)
Total adjustments	365,134	(406,823)
Net cash used in operating activities	(152,994)	(657,145)
Cash Flows from Investing Activities:
Return of Investment Braodway Partners Fund II	0	2,750
Payments received on notes receivable	0	405
Payments disbursed for capital improvements	(51,114)	(5,157)
Net cash used in investing activities	(51,114)	(2,002)
Cash Flows from Financing Activities:
Proceeds from mortgage	0	1,750,000
Payment of line of credit	0	(500,000)
Principal payments on mortgage debt	(22,044)	(442,874)
Net cash (used in) provided by financing activities	(22,044)	807,126
Net (decrease) increase in Cash and Cash Equivalents	(226,152)	147,979
Cash and Cash Equivalents, Beginning of period	442,922	442,613
Cash and Cash Equivalents, End of period	216,770	590,592
Supplemental cash flow information:
Interest paid in cash	$ 79,394	45,535
Issuance of stock optionns for deferred conpensation		$ 185,489